HDFC Mutual Fund Reduces Stake in Piramal Pharma Limited
HDFC Mutual Fund has reduced its shareholding in Piramal Pharma Limited by 2.005% as of July 14, 2026. The transaction was executed through the open market.The reduction brings the aggregate holding of the Schemes of HDFC Mutual Fund in Piramal Pharma Limited to 7.015% of the paid up equity share capital as of July 14, 2026. This follows a previous reported holding of 9.034% as of June 26, 2025.
The transaction involved the disposal of 2,66,88,471 shares carrying voting rights. Following this sale, the total number of shares held by the fund's schemes stands at 9,33,93,655.
The financial details regarding the change in shareholding are outlined in the table below:
| Category | Before Sale (as of June 26, 2025) | Transaction Details | After Sale (as of July 14, 2026) |
|---|---|---|---|
| Number of Shares | 12,00,82,126 | 2,66,88,471 | 9,33,93,655 |
| Percentage Holding | 9.020% | 2.005% | 7.015% |
The paid up equity share capital of Piramal Pharma Limited is reported as Rs. 13,31,34,81,300/-, comprising 1,33,13,48,130 Equity Shares of Rs. 10/- each. This figure remains unchanged following the recent transaction.
The Schemes of HDFC Mutual Fund involved in this holding include:
- HDFC BSE 500 ETF
- HDFC BSE 500 Index Fund
- HDFC Focused Fund
- HDFC Flexi Cap Fund
- HDFC Manufacturing Fund
- HDFC NIFTY500 MULTICAP 50:25:25 INDEX FUND
- HDFC NIFTY SMALLCAP 250 ETF
PPLPHARMA Stock Price Movement
Piramal Pharma Limited shares are slipping by 0.09% to ₹174.63 as of 10:53 AM in live trading. The stock is seeing activity on a volume of 1.22 million shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.